Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Cochlear Limited

Njord Medtech develops solutions for unmet needs in patient handling and radiology to improve healthcare efficiency and quality of care, self-described focus on sustainability.

Njord Medtech

Otolith Labs develops a noninvasive wearable solution for chronic vertigo through patented technology utilizing non-invasive Vestibular Resonance Therapy (nVRT).

Otolith Labs

Flanders Semiconductors is a non-profit organization that supports its members and their solutions in the semiconductor industry at national and international levels.

Flanders Semiconductors

Cochlear is involved in providing hearing solutions, including cochlear implants and related products.

Metric
Company Name	Cochlear Limited	Njord Medtech	Otolith Labs	Flanders Semiconductors
Symbol	COH
MSH ID	COM:COCHLEAR	COM:NJORDMEDTECH	COM:OTOLITHLABS	ORG:FLANDERS-SEMICONDUCTORS
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Technology
Industry	Medical - Devices	Medical Devices	Medical Devices	Semiconductors
Country	AU	SE	US	BE
Stage		Venture Round
Employee Count	4.80K
Website	cochlear.com	njordmedtech.com	otolithlabs.com	flanders-semiconductors.org
LinkedIn		njord-medtech		flanders-semiconductors
Founders

Metric
Market Cap	13.66B
Enterprise Value
Monthly Web Traffic		164
Web Traffic Growth
Valuation
Raised Capital		785.79K

Metric
Revenue	1.44B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.08B
EBITDA	387.47M
Operating Income	333.22M
Net Income	227.98M
EPS	3.48
Diluted EPS	3.47
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.75
Operating Profit Margin	0.23
EBITDA Margin	0.27
Net Profit Margin	0.16
Return on Equity	0.20
Return on Assets	0.14
Return on Capital Employed	0.25

COM:COCHLEAR

Cochlear

Last Close

298.23

25/11 05:10

Market Cap

21.38B

Beta: -

Volume Today

191.72K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	67.35
P/B Ratio	11.58
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	10.38
EV Multiple	39.91

Metric
Days Sales Outstanding	82.48
Days Payables Outstanding	202.25
Days Inventory Outstanding	254.29
Operating Cycle	335.43
Cash Conversion Cycle	138.54
Asset Turnover	0.86

Metric
Operating Cash Flow	248.43M
Free Cash Flow	191.05M
Cash Flow to Debt	2.08
Operating Cash Flow/Sales	0.20
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	328.17M
Accounts Receivable	-34.25M
Inventory	250.22M
Goodwill	164.66M
Debt to Capitalization	0.12
Debt to Assets	0.08
Current Ratio	2.36
Quick Ratio	1.94

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.13
SG&A to Revenue	0.11